Sort
261,768 grants matching “gene therapy”
Role of inflammation in epigenetic alterations of metastatic cancer cells
$845,247Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
The Functional Consequences of the 17q12 Asthma Susceptibility Locus
$845,233Benjamin Alexander Raby · Brigham And Women'S Hospital · R01 · FY2015 · HL
Role of lactate transporters in pulmonary fibrosis
$845,190William Michael Oldham · Brigham And Women'S Hospital · R01 · FY2024 · HL
Clinical and Genetic Study of Prescription Opioid Addiction
$845,183Vanessa Troiani · Geisinger Clinic · R01 · FY2017 · DA
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR HIV/AIDS
$845,162Miriam Hospital · U01 · FY2001 · AI
The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia
$845,100Julian Abrams · Columbia University Health Sciences · R01 · FY2022 · CA
Defining the Mechanisms of Immune Escape After Adoptive T cell Therapies
$845,088Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
$845,062Darell D Bigner · Duke University · R35 · FY2020 · CA
Understanding the Cognitive Impact of Early Life Epilepsy
$845,000Frances E Jensen · Boston Children'S Hospital · DP1 · FY2009 · OD
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$845,000Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2021 · CA
Understanding the Cognitive Impact of Early Life Epilepsy
$845,000Frances E Jensen · Boston Children'S Hospital · DP1 · FY2008 · OD
Understanding the Cognitive Impact of Early Life Epilepsy
$845,000Frances E Jensen · Boston Children'S Hospital · DP1 · FY2007 · OD
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$844,999Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2022 · CA
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$844,999Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Targeting Lewy Body Specific Pathology Using Biomarkers
$844,960Karen S Marder · Columbia University Health Sciences · U01 · FY2017 · NS
Genomically rewritten and tailored humanized mouse models for various organ disorders
$844,954Jef D Boeke · New York University School Of Medicine · R24 · FY2025 · OD
Genomic approach to identification of microglial networks involved in Alzheimerâs disease risk
$844,934Alison M Goate · Icahn School Of Medicine At Mount Sinai · U01 · FY2019 · AG
Host control in Coccidioidomycosis
$844,908University Of Arizona · P01 · FY2004 · AI
Small Molecule Therapeutics for Myocardial Ischemia
$844,903Prakash Narayan · Angion Biomedica Corporation · R44 · FY2006 · HL
Molecular studies of neural histone monoaminylation in normal and aberrant brain plasticity
$844,899Ian S. Maze · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · MH
Molecular studies of neural histone monoaminylation in normal and aberrant brain plasticity
$844,899Ian S. Maze · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · MH
Studies Of Hereditary Neurological Disease: Disease Gene Identification
$844,876Kenneth Fischbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
Development of an oral liver-targeted prime-and-trap malaria vaccine
$844,865Sean C Murphy · University Of Washington · U01 · FY2022 · AI
The Genetic Basis of Conotruncal Defects
$844,753Elizabeth Goldmuntz · Children'S Hosp Of Philadelphia · U01 · FY2013 · HL
Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications
$844,657Sandeep Kasoji · Triangle Biotechnology, Inc. · R44 · FY2020 · CA